275 related articles for article (PubMed ID: 25986588)
1. Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering.
Griffiths PC; Cattoz B; Ibrahim MS; Anuonye JC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):218-22. PubMed ID: 25986588
[TBL] [Abstract][Full Text] [Related]
2. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.
Xu Q; Ensign LM; Boylan NJ; Schön A; Gong X; Yang JC; Lamb NW; Cai S; Yu T; Freire E; Hanes J
ACS Nano; 2015 Sep; 9(9):9217-27. PubMed ID: 26301576
[TBL] [Abstract][Full Text] [Related]
3. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
4. On the synthesis of mucus permeating nanocarriers.
Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles.
Abdulkarim M; Agulló N; Cattoz B; Griffiths P; Bernkop-Schnürch A; Borros SG; Gumbleton M
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):230-8. PubMed ID: 25661585
[TBL] [Abstract][Full Text] [Related]
6. Mucus adhesion vs. mucus penetration? Screening nanomaterials for nasal inhalation by MD simulation.
Gao X; Xiong Y; Chen H; Gao X; Dai J; Zhang Y; Zou W; Gao Y; Jiang Z; Han B
J Control Release; 2023 Jan; 353():366-379. PubMed ID: 36462640
[TBL] [Abstract][Full Text] [Related]
7. An overview of gastrointestinal mucus rheology under different pH conditions and introduction to pH-dependent rheological interactions with PLGA and chitosan nanoparticles.
Ruiz-Pulido G; Medina DI
Eur J Pharm Biopharm; 2021 Feb; 159():123-136. PubMed ID: 33387633
[TBL] [Abstract][Full Text] [Related]
8. A free-floating mucin layer to investigate the effect of the local microenvironment in lungs on mucin-nanoparticle interactions.
Wan F; Herzberg M; Huang Z; Hassenkam T; Nielsen HM
Acta Biomater; 2020 Mar; 104():115-123. PubMed ID: 31945503
[TBL] [Abstract][Full Text] [Related]
9. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
10. Molecular Insight into Drug-Loading Capacity of PEG-PLGA Nanoparticles for Itraconazole.
Wilkosz N; Łazarski G; Kovacik L; Gargas P; Nowakowska M; Jamróz D; Kepczynski M
J Phys Chem B; 2018 Jul; 122(28):7080-7090. PubMed ID: 29927603
[TBL] [Abstract][Full Text] [Related]
11. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
12. Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus.
Xu Q; Boylan NJ; Cai S; Miao B; Patel H; Hanes J
J Control Release; 2013 Sep; 170(2):279-86. PubMed ID: 23751567
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer.
Alp G; Aydogan N
Eur J Pharm Biopharm; 2020 Apr; 149():45-57. PubMed ID: 32014491
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.
Yang M; Lai SK; Yu T; Wang YY; Happe C; Zhong W; Zhang M; Anonuevo A; Fridley C; Hung A; Fu J; Hanes J
J Control Release; 2014 Oct; 192():202-8. PubMed ID: 25090196
[TBL] [Abstract][Full Text] [Related]
15. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
[TBL] [Abstract][Full Text] [Related]
16. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
17. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
18. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications.
Zhang K; Tang X; Zhang J; Lu W; Lin X; Zhang Y; Tian B; Yang H; He H
J Control Release; 2014 Jun; 183():77-86. PubMed ID: 24675377
[TBL] [Abstract][Full Text] [Related]
19. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
